TORONTO, November 27 /CNW/ - Kyto Biopharma Inc. (OTCBB:KBPH - News), (“Kyto”) announces it has signed a non binding Letter of Intent to Helios Petroleum Holding, AG (“Helios”) a private company incorporated in Switzerland. The transaction is subject to Helios raising successfully US$5MM through Credifinance Securities Limited. Upon closing, Kyto will issue Common Shares of Kyto to Helios shareholders and will transfer all its Intellectual Property to its wholly owned Canadian subsidiary, B.Twelve Limited. For disclosure purposes, Credifinance Capital Corp, the parent of the Agent, is the controlling shareholder of Kyto and Georges Benarroch, President/CEO of Credifinance Securities Limited, Credifinance Capital Corp. and Kyto Biopharma Inc. will be on the board of directors of Helios.
